Matches in DBpedia 2016-04 for { <http://dbpedia.org/resource/Empagliflozin> ?p ?o }
Showing triples 1 to 95 of
95
with 100 triples per page.
- Empagliflozin abstract "Empagliflozin (trade name Jardiance) is a drug of the gliflozin class, approved for the treatment of type 2 diabetes in adults in 2014. It was developed by Boehringer Ingelheim and Eli Lilly and Company.Empagliflozin is an inhibitor of the sodium glucose co-transporter-2 (SGLT-2), and causes sugar in the blood to be excreted by the kidneys and eliminated in urine.".
- Empagliflozin atcPrefix "A10".
- Empagliflozin atcSuffix "BX12".
- Empagliflozin casNumber "864070-44-0".
- Empagliflozin chEBI "82720".
- Empagliflozin fdaUniiCode "HDC1R2M35U".
- Empagliflozin iupacName "(2S,3R,4R,5S,6R)-2-[4-chloro-3-[[4-[(3S)-oxolan-3-yl]oxyphenyl]methyl]phenyl]-6-(hydroxymethyl)oxane-3,4,5-triol".
- Empagliflozin pubchem "11949646".
- Empagliflozin thumbnail Empagliflozin.svg?width=300.
- Empagliflozin wikiPageID "37113247".
- Empagliflozin wikiPageLength "7302".
- Empagliflozin wikiPageOutDegree "22".
- Empagliflozin wikiPageRevisionID "707010986".
- Empagliflozin wikiPageWikiLink Boehringer_Ingelheim.
- Empagliflozin wikiPageWikiLink Category:Ethers.
- Empagliflozin wikiPageWikiLink Category:Glucosides.
- Empagliflozin wikiPageWikiLink Category:SGLT2_inhibitors.
- Empagliflozin wikiPageWikiLink Diabetes_mellitus_type_2.
- Empagliflozin wikiPageWikiLink Diabetic_ketoacidosis.
- Empagliflozin wikiPageWikiLink Eli_Lilly_and_Company.
- Empagliflozin wikiPageWikiLink linagliptin.
- Empagliflozin wikiPageWikiLink European_Medicines_Agency.
- Empagliflozin wikiPageWikiLink Food_and_Drug_Administration.
- Empagliflozin wikiPageWikiLink Gliflozin.
- Empagliflozin wikiPageWikiLink Kidney.
- Empagliflozin wikiPageWikiLink Myocardial_infarction.
- Empagliflozin wikiPageWikiLink Nephron.
- Empagliflozin wikiPageWikiLink Pharmaceutical_drug.
- Empagliflozin wikiPageWikiLink Placebo.
- Empagliflozin wikiPageWikiLink Proximal_convoluted_tubule.
- Empagliflozin wikiPageWikiLink Renal_glucose_reabsorption.
- Empagliflozin wikiPageWikiLink SGLT2.
- Empagliflozin wikiPageWikiLink Stroke.
- Empagliflozin wikiPageWikiLink Urine.
- Empagliflozin wikiPageWikiLinkText "Empagliflozin".
- Empagliflozin wikiPageWikiLinkText "empagliflozin".
- Empagliflozin atcPrefix "A10".
- Empagliflozin atcSuffix "BX12".
- Empagliflozin c "23".
- Empagliflozin casNumber "864070".
- Empagliflozin chebi "82720".
- Empagliflozin chemspiderid "10123957".
- Empagliflozin cl "1".
- Empagliflozin h "27".
- Empagliflozin inchi "1".
- Empagliflozin inchikey "OBWASQILIWPZMG-QZMOQZSNBH".
- Empagliflozin iupacName "-2".
- Empagliflozin iupharLigand "4754".
- Empagliflozin legalStatus "Rx-only".
- Empagliflozin molecularWeight "450.91".
- Empagliflozin o "7".
- Empagliflozin pregnancyUs "C".
- Empagliflozin pubchem "11949646".
- Empagliflozin routesOfAdministration "Oral".
- Empagliflozin smiles "C1COC[C@H]1OC2=CC=CCC3=CCl".
- Empagliflozin stdinchi "1".
- Empagliflozin stdinchikey "OBWASQILIWPZMG-QZMOQZSNSA-N".
- Empagliflozin tradename "Jardiance".
- Empagliflozin unii "HDC1R2M35U".
- Empagliflozin width "300".
- Empagliflozin wikiPageUsesTemplate Template:Drugbox.
- Empagliflozin wikiPageUsesTemplate Template:Drugs.com.
- Empagliflozin wikiPageUsesTemplate Template:Ebicite.
- Empagliflozin wikiPageUsesTemplate Template:Oral_hypoglycemics_and_insulin_analogs.
- Empagliflozin wikiPageUsesTemplate Template:Reflist.
- Empagliflozin subject Category:Ethers.
- Empagliflozin subject Category:Glucosides.
- Empagliflozin subject Category:SGLT2_inhibitors.
- Empagliflozin hypernym Drug.
- Empagliflozin type Biomolecule.
- Empagliflozin type ChemicalSubstance.
- Empagliflozin type Drug.
- Empagliflozin type Biomolecule.
- Empagliflozin type Carbohydrate.
- Empagliflozin type Chemical.
- Empagliflozin type Drug.
- Empagliflozin type Glycoside.
- Empagliflozin type ChemicalObject.
- Empagliflozin type Thing.
- Empagliflozin type Q8386.
- Empagliflozin comment "Empagliflozin (trade name Jardiance) is a drug of the gliflozin class, approved for the treatment of type 2 diabetes in adults in 2014. It was developed by Boehringer Ingelheim and Eli Lilly and Company.Empagliflozin is an inhibitor of the sodium glucose co-transporter-2 (SGLT-2), and causes sugar in the blood to be excreted by the kidneys and eliminated in urine.".
- Empagliflozin label "Empagliflozin".
- Empagliflozin sameAs Q5373824.
- Empagliflozin sameAs أمباغليفلوزين.
- Empagliflozin sameAs Empagliflozina.
- Empagliflozin sameAs Empagliflozine.
- Empagliflozin sameAs エンパグリフロジン.
- Empagliflozin sameAs m.0n49z1d.
- Empagliflozin sameAs Empagliflozin.
- Empagliflozin sameAs Empagliflozin.
- Empagliflozin sameAs Q5373824.
- Empagliflozin sameAs 恩格列淨.
- Empagliflozin wasDerivedFrom Empagliflozin?oldid=707010986.
- Empagliflozin depiction Empagliflozin.svg.
- Empagliflozin isPrimaryTopicOf Empagliflozin.